PDCO · Patterson Companies, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q3 '25 | Q2 '25 | Q1 '25 | Q2 '24 | Q3 '24 | Q1 '24 | Q2 '23 | Q3 '23 | Q1 '23 | Q2 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.57B | $1.67B | $1.54B | $1.65B | $1.62B | $1.58B | $1.63B | $1.60B | $1.52B | $1.65B |
| Cost of Revenue | $1.25B | $1.35B | $1.23B | $1.31B | $1.27B | $1.26B | $1.30B | $1.26B | $1.21B | $1.32B |
| Gross Profit | $320.82M | $328.09M | $312.61M | $339.03M | $351.01M | $319.06M | $328.09M | $342.96M | $312.13M | $326.44M |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | - | - | - | - | - | - | - | - | - | - |
| Total Operating Expenses | $275.38M | $290.46M | $283.24M | $282.12M | $280.99M | $280.83M | $267.99M | $267.04M | $277.29M | $263.57M |
| D&A | - | - | $13.11M | - | - | $11.41M | - | - | $10.83M | - |
| Operating Income | $45.44M | $37.64M | $29.37M | $56.90M | $70.01M | $38.22M | $60.09M | $75.92M | $34.84M | $62.86M |
| Interest Expense | $10.75M | $11.80M | $13.22M | $10.64M | $11.72M | $9.51M | $7.54M | $9.73M | $5.56M | $5.52M |
| Income Tax | $11.66M | $8.85M | $4.22M | $13.50M | $14.35M | $9.48M | $17.11M | $15.44M | $6.80M | $16.20M |
| Net Income | $31.25M | $26.77M | $13.71M | $39.96M | $47.70M | $31.23M | $54.07M | $53.93M | $24.59M | $48.33M |
| EPS - Basic | $0.35 | $0.30 | $0.16 | $0.42 | $0.52 | $0.33 | $0.56 | $0.55 | $0.25 | $0.50 |
| EPS - Diluted | $0.35 | $0.30 | $0.15 | $0.42 | $0.52 | $0.32 | $0.55 | $0.55 | $0.25 | $0.49 |
Balance Sheet
| Line item | Q3 '25 | Q2 '25 | Q1 '25 | Q2 '24 | Q3 '24 | Q1 '24 | Q2 '23 | Q3 '23 | Q1 '23 | Q2 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $135.00M | $157.94M | $148.08M | $114.46M | $124.00M | $108.57M | $159.67M | $147.29M | $149.56M | $142.01M |
| Accounts Receivable | $469.92M | $532.04M | $442.34M | $547.29M | $484.53M | $408.93M | $477.38M | $422.71M | $370.35M | $447.16M |
| Inventory | $889.35M | $823.69M | $849.50M | $782.90M | $902.73M | $912.67M | $795.07M | $939.10M | $874.82M | $785.60M |
| Accounts Payable | $644.86M | $731.26M | $656.98M | $745.38M | $683.30M | $717.43M | $724.99M | $702.46M | $655.65M | $681.32M |
| Current Assets | $1.84B | $1.84B | $1.76B | $1.78B | $1.83B | $1.77B | $1.78B | $1.84B | $1.71B | $1.68B |
| Total Assets | $2.83B | $2.85B | $2.87B | $2.90B | $2.94B | $2.88B | $2.88B | $2.94B | $2.76B | $2.74B |
| Current Liabilities | $1.31B | $1.34B | $1.36B | $1.33B | $1.28B | $1.09B | $1.09B | $1.17B | $1.04B | $1.02B |
| Long-term Debt | $321.76M | $325.40M | $327.15M | $328.91M | $448.22M | $450.60M | $451.23M | $451.91M | $488.81M | $488.55M |
| Total Liabilities | $1.84B | $1.88B | $1.92B | $1.90B | $1.97B | $1.77B | $1.76B | $1.84B | $1.73B | $1.70B |
| Stockholders' Equity | $989.56M | $963.01M | $951.99M | $1.00B | $971.48M | $1.11B | $1.12B | $1.10B | $1.03B | $1.04B |
| Retained Earnings | $806.80M | $775.54M | $772.00M | $831.48M | $802.88M | $948.73M | $972.13M | $962.91M | $905.63M | $921.70M |
Cash Flow
| Line item | Q3 '25 | Q2 '25 | Q1 '25 | Q2 '24 | Q3 '24 | Q1 '24 | Q2 '23 | Q3 '23 | Q1 '23 | Q2 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | ($284.97M) | - | - | ($253.37M) | - | - | ($302.54M) | - |
| Investing Cash Flow | - | - | $258.33M | - | - | $223.82M | - | - | $238.35M | - |
| Financing Cash Flow | - | - | $58.79M | - | - | ($23.12M) | - | - | $73.44M | - |
| CapEx | - | - | $13.51M | - | - | $17.09M | - | - | $14.55M | - |
| Free Cash Flow | - | - | ($298.48M) | - | - | ($270.45M) | - | - | ($317.09M) | - |
Ratios
| Metric | Q3 '25 | Q2 '25 | Q1 '25 | Q2 '24 | Q3 '24 | Q1 '24 | Q2 '23 | Q3 '23 | Q1 '23 | Q2 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 20.4% | 19.6% | 20.3% | 20.5% | 21.7% | 20.2% | 20.2% | 21.4% | 20.5% | 19.8% |
| Operating margin | 2.9% | 2.2% | 1.9% | 3.4% | 4.3% | 2.4% | 3.7% | 4.7% | 2.3% | 3.8% |
| EBITDA margin | - | - | 2.8% | - | - | 3.1% | - | - | 3.0% | - |
| Net margin | 2.0% | 1.6% | 0.9% | 2.4% | 3.0% | 2.0% | 3.3% | 3.4% | 1.6% | 2.9% |
| Free cash flow margin | - | - | -19.4% | - | - | -17.2% | - | - | -20.8% | - |
| FCF / Net income | - | - | -21.76 | - | - | -8.66 | - | - | -12.90 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | - | - | - | - |
| Effective tax rate | 27.2% | 24.8% | 23.5% | 25.3% | 23.1% | 23.3% | 24.0% | 22.3% | 21.7% | 25.1% |
| Return on assets | 1.1% | 0.9% | 0.5% | 1.4% | 1.6% | 1.1% | 1.9% | 1.8% | 0.9% | 1.8% |
| Return on equity | 3.2% | 2.8% | 1.4% | 4.0% | 4.9% | 2.8% | 4.8% | 4.9% | 2.4% | 4.6% |
| Return on invested capital | 2.5% | 2.2% | 1.8% | 3.2% | 3.8% | 1.9% | 2.9% | 3.8% | 1.8% | 3.1% |
| Liquidity | ||||||||||
| Current ratio | 1.41 | 1.37 | 1.30 | 1.33 | 1.43 | 1.63 | 1.64 | 1.57 | 1.63 | 1.65 |
| Quick ratio | 0.73 | 0.76 | 0.67 | 0.75 | 0.72 | 0.79 | 0.91 | 0.77 | 0.80 | 0.88 |
| Cash ratio | 0.10 | 0.12 | 0.11 | 0.09 | 0.10 | 0.10 | 0.15 | 0.13 | 0.14 | 0.14 |
| Leverage | ||||||||||
| Debt / Equity | 0.33 | 0.34 | 0.34 | 0.33 | 0.46 | 0.41 | 0.40 | 0.41 | 0.48 | 0.47 |
| Debt / Assets | 0.11 | 0.11 | 0.11 | 0.11 | 0.15 | 0.16 | 0.16 | 0.15 | 0.18 | 0.18 |
| Debt / EBITDA | - | - | 7.70 | - | - | 9.08 | - | - | 10.70 | - |
| Interest coverage | 4.2x | 3.2x | 2.2x | 5.3x | 6.0x | 4.0x | 8.0x | 7.8x | 6.3x | 11.4x |
| Equity multiplier | 2.86 | 2.95 | 3.02 | 2.89 | 3.03 | 2.60 | 2.58 | 2.67 | 2.69 | 2.63 |
| Liabilities / Assets | 0.65 | 0.66 | 0.67 | 0.65 | 0.67 | 0.61 | 0.61 | 0.63 | 0.63 | 0.62 |
| Efficiency | ||||||||||
| Asset turnover | 0.56 | 0.59 | 0.54 | 0.57 | 0.55 | 0.55 | 0.56 | 0.54 | 0.55 | 0.60 |
| Inventory turnover | 1.41 | 1.63 | 1.45 | 1.68 | 1.40 | 1.38 | 1.63 | 1.34 | 1.38 | 1.68 |
| Days sales outstanding | 109d | 116d | 105d | 121d | 109d | 95d | 107d | 96d | 89d | 99d |
| Days inventory outstanding | 259d | 223d | 252d | 218d | 260d | 265d | 224d | 272d | 264d | 217d |
| Days payable outstanding | 188d | 198d | 195d | 207d | 197d | 208d | 204d | 204d | 198d | 188d |
| Cash conversion cycle | 180d | 141d | 162d | 131d | 173d | 151d | 127d | 165d | 155d | 128d |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | -2.7% | 1.3% | -2.2% | 1.6% | 1.0% | 3.5% | -1.4% | 0.3% | -5.7% | 6.2% |
| Revenue CAGR (3y) | -0.5% | 0.5% | -1.5% | 2.1% | 1.4% | 8.2% | 4.7% | 4.7% | 4.5% | 5.5% |
| Revenue CAGR (5y) | 2.4% | 3.4% | 2.9% | 3.3% | 3.0% | 3.4% | 3.3% | 3.1% | 3.2% | 3.1% |
| Gross profit growth (YoY) | -8.6% | -3.2% | -2.0% | 3.3% | 2.3% | 2.2% | 0.5% | 1.9% | 12.4% | 1.9% |
| Operating income growth (YoY) | -35.1% | -33.9% | -23.2% | -5.3% | -7.8% | 9.7% | -4.4% | 24.8% | - | -14.7% |
| Net income growth (YoY) | -34.5% | -33.0% | -56.1% | -26.1% | -11.5% | 27.0% | 11.9% | -5.4% | -27.7% | -10.6% |
| EPS growth (YoY) | -32.7% | -28.6% | -53.1% | -23.6% | -5.5% | 28.0% | 12.2% | -5.2% | -28.6% | -12.5% |
| EPS CAGR (3y) | -15.5% | -15.1% | -24.6% | -9.1% | 1.3% | 8.6% | - | 31.8% | -7.9% | 16.5% |
| EPS CAGR (5y) | 7.8% | - | -14.1% | 6.3% | 9.5% | - | 5.0% | -14.2% | -5.4% | 0.4% |
| FCF growth (YoY) | - | - | -10.4% | - | - | 14.7% | - | - | 1.3% | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 1.9% | -3.8% | -14.3% | -10.4% | -11.8% | 8.2% | 7.3% | 5.6% | 4.8% | 8.1% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2024-04-27.
Business segments
$6.57B totalAnimal Health Segment$4.07B · 61.9%
Dental Supply$2.49B · 37.9%
Corporate$12.57M · 0.2%
Product / service
$6.57B totalConsumable And Printed Products$5.27B · 80.3%
Equipment$888.60M · 13.5%
Value Added Services And Other$405.66M · 6.2%
Geographic
$6.57B totalUS$5.44B · 82.8%
GB$759.18M · 11.6%
CA$370.36M · 5.6%
Peer comparison
Same SIC group: Wholesale-Medical, Dental & Hospital Equipment & Supplies
Comparing PATTERSON COMPANIES against the 2 most active filers in the same SIC group.